These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32805459)

  • 1. Evaluation of cobalt(III) complexes as potential hypoxia-responsive carriers of esculetin.
    Palmeira-Mello MV; Caballero AB; Ribeiro JM; de Souza-Fagundes EM; Gamez P; Lanznaster M
    J Inorg Biochem; 2020 Oct; 211():111211. PubMed ID: 32805459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of cobalt(III)-phenylalanine complexes for hypoxia-activated drug delivery.
    de Souza ICA; Santana SS; Gómez JG; Guedes GP; Madureira J; Quintal SMO; Lanznaster M
    Dalton Trans; 2020 Nov; 49(45):16425-16439. PubMed ID: 32692333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 5-hydroxy-1,4-naphthoquinone-cobalt(III) complexes for hypoxia-activated drug delivery.
    de Mello MVP; Cebrián-Torrejón G; Pereira JR; Dos Santos Moreira C; Gomes CBSMR; da Rocha DR; de Souza Fagundes EM; Ferreira GB; Lanznaster M
    J Inorg Biochem; 2019 Oct; 199():110756. PubMed ID: 31299378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of cobalt(iii)-triazole systems as prototypes for hypoxia-activated drug delivery.
    de Souza IC; Faro LV; Pinheiro CB; Gonzaga DT; da Silva Fde C; Ferreira VF; Miranda Fda S; Scarpellini M; Lanznaster M
    Dalton Trans; 2016 Sep; 45(35):13671-4. PubMed ID: 27488398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and cytotoxicity studies of Co(III)-flavonolato complexes.
    Kozsup M; Zhou X; Farkas E; Bényei AC; Bonnet S; Patonay T; Kónya K; Buglyó P
    J Inorg Biochem; 2021 Apr; 217():111382. PubMed ID: 33588278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient hydrolytic cleavage of plasmid DNA by chloro-cobalt(II) complexes based on sterically hindered pyridyl tripod tetraamine ligands: synthesis, crystal structure and DNA cleavage.
    Massoud SS; Perkins RS; Louka FR; Xu W; Le Roux A; Dutercq Q; Fischer RC; Mautner FA; Handa M; Hiraoka Y; Kreft GL; Bortolotto T; Terenzi H
    Dalton Trans; 2014 Jul; 43(26):10086-103. PubMed ID: 24872210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-bridged cyclen or cyclam Co(III) complexes containing cytotoxic ligands as hypoxia-activated prodrugs.
    Chang JY; Lu GL; Stevenson RJ; Brothers PJ; Clark GR; Botting KJ; Ferry DM; Tercel M; Wilson WR; Denny WA; Ware DC
    Inorg Chem; 2013 Jul; 52(13):7688-98. PubMed ID: 23773210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the replacement of tripodal 4N donors by two 2N chelators on the redox and cytotoxic activity of maltolato and deferipronato containing Co(III) complexes.
    Nagy S; Tóth E; Kacsir I; Makai A; Bényei AC; Buglyó P
    J Inorg Biochem; 2021 Jul; 220():111372. PubMed ID: 33962134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the properties and reactivity of naphthoquinone-cobalt(III) prototypes for bioreductive prodrugs.
    Bustamante FL; Miranda FS; Castro FA; Resende JA; Pereira MD; Lanznaster M
    J Inorg Biochem; 2014 Mar; 132():37-44. PubMed ID: 24326134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
    Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR
    Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the ancillary ligand on the potential of cobalt(iii) complexes to act as chaperones for hydroxamic acid-based drugs.
    Green BP; Renfrew AK; Glenister A; Turner P; Hambley TW
    Dalton Trans; 2017 Nov; 46(45):15897-15907. PubMed ID: 29116280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and albumin binding capabilities of quinizarin containing ternary cobalt(III) complexes.
    Kozsup M; Dömötör O; Nagy S; Farkas E; Enyedy ÉA; Buglyó P
    J Inorg Biochem; 2020 Mar; 204():110963. PubMed ID: 31874363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and biological evaluation of Co(III) complexes with quinolone drugs.
    Kozsup M; Farkas E; Bényei AC; Kasparkova J; Crlikova H; Brabec V; Buglyó P
    J Inorg Biochem; 2019 Apr; 193():94-105. PubMed ID: 30703748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-Responsive Cobalt Complexes in Tumor Spheroids: Laser Ablation Inductively Coupled Plasma Mass Spectrometry and Magnetic Resonance Imaging Studies.
    O'Neill ES; Kaur A; Bishop DP; Shishmarev D; Kuchel PW; Grieve SM; Figtree GA; Renfrew AK; Bonnitcha PD; New EJ
    Inorg Chem; 2017 Aug; 56(16):9860-9868. PubMed ID: 28766939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cobalt complexes with tripodal ligands: implications for the design of drug chaperones.
    Bonnitcha PD; Kim BJ; Hocking RK; Clegg JK; Turner P; Neville SM; Hambley TW
    Dalton Trans; 2012 Oct; 41(37):11293-304. PubMed ID: 22885674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligand.
    Crlikova H; Kostrhunova H; Pracharova J; Kozsup M; Nagy S; Buglyó P; Brabec V; Kasparkova J
    J Biol Inorg Chem; 2020 Mar; 25(2):339-350. PubMed ID: 32112290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cobalt(III) hydroxamic acid complexes based on a tris(2-pyridylmethyl)amine scaffold: reactivity toward cysteine methyl ester.
    Alimi M; Allam A; Selkti M; Tomas A; Roussel P; Galardon E; Artaud I
    Inorg Chem; 2012 Sep; 51(17):9350-6. PubMed ID: 22905650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching on oxygen activation by cobalt complexes of pentadentate ligands.
    Vad MS; Nielsen A; Lennartson A; Bond AD; McGrady JE; McKenzie CJ
    Dalton Trans; 2011 Oct; 40(40):10698-707. PubMed ID: 21866283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomolecular Interaction, Anti-Cancer and Anti-Angiogenic Properties of Cobalt(III) Schiff Base Complexes.
    Ambika S; Manojkumar Y; Arunachalam S; Gowdhami B; Meenakshi Sundaram KK; Solomon RV; Venuvanalingam P; Akbarsha MA; Sundararaman M
    Sci Rep; 2019 Feb; 9(1):2721. PubMed ID: 30804454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses of 8-quinolinolatocobalt(III) complexes containing cyclen based auxiliary ligands as models for hypoxia-activated prodrugs.
    Chang JY; Stevenson RJ; Lu GL; Brothers PJ; Clark GR; Denny WA; Ware DC
    Dalton Trans; 2010 Dec; 39(48):11535-50. PubMed ID: 21103540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.